☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Allergan Signs an Exclusive Option and License Agreement with Exicure to Discover and Develop SNA-based Therapies for Hair Loss Di...
November 15, 2019
AstraZeneca and MSD Report FDA's Acceptance of NDA for Selumetinib in Patients with Neurofibromatosis Type 1
November 15, 2019
BeiGene's Brukinsa (zanubrutinib) Receives the US FDA's Accelerated Approval for Patients with Mantle Cell Lymphoma Who Received A...
November 15, 2019
Shionogi's Fetroja (cefiderocol) Receives the US FDA's Approval for the Treatment of Complicated Urinary Tract Infections
November 15, 2019
Sarepta Signs a License Agreement with Stride Bio to Develop In vivo AAV-Based Gene Therapies
November 15, 2019
Stanford Medicine Reports Results of Apple Heart Study for Detecting Atrial Fibrillation
November 15, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions